Vikram Nath Sahni
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Vikram Nath Sahni has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Dev Ram Sahni
Department of Dermatology, University of Utah Health, Salt Lake City, Utah, USA
6 shared publications - Aaron M. Secrest
Department of Dermatology, University of Utah, Salt Lake City, USA
3 shared publications - Christopher M. Hull
Department of Dermatology, University of Utah Health, Salt Lake City, UT, USA
3 shared publications - Aishwarya Suresh
Department of Otolaryngology‐Head and Neck Surgery Loma Linda University Health Loma Linda California USA
2 shared publications - B.C. Ma
School of Medicine Virginia Commonwealth University Richmond VA 23223 USA
2 shared publications - Douglas L. Powell
Department of Dermatology, University of Utah Health, Salt Lake, UT, USA
2 shared publications
Latest Publications
- Open Access
- 4 December 2025
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 194 (4) , 789-791
Ultraviolet A1 phototherapy for improvement of hand function in scleroderma: a blinded prospective study
Effective tools for improving sclerotic hand changes in patients with systemic sclerosis are lacking; thus, we conducted a single-blind prospective randomized clinical trial investigating the impact of UVA1 phototherapy on scleroderma of the hands. Seven patients were unilaterally treated, and we found no evidence of significant change in Hand Mobility in Scleroderma (HAMIS) scores after 30 treatments. However, patients did report significant health-related outcome changes in the emotional, symptomatic and functional domains of Skindex-16 [β = –34.1 (95% CI –47.0 to –21.3), –26.3 (–38.1 to –14.4) and –13.1 (–20.9 to –5.41), respectively].
- 4 December 2025
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 194 (4) , 789-791
Open AccessUltraviolet A1 phototherapy for improvement of hand function in scleroderma: a blinded prospective study
Effective tools for improving sclerotic hand changes in patients with systemic sclerosis are lacking; thus, we conducted a single-blind prospective randomized clinical trial investigating the impact of UVA1 phototherapy on scleroderma of the hands. Seven patients were unilaterally treated, and we found no evidence of significant change in Hand Mobility in Scleroderma (HAMIS) scores after 30 treatments. However, patients did report significant health-related outcome changes in the emotional, symptomatic and functional domains of Skindex-16 [β = –34.1 (95% CI –47.0 to –21.3), –26.3 (–38.1 to –14.4) and –13.1 (–20.9 to –5.41), respectively].
- 19 September 2025
- Published by SAGE Publications in Dermatitis®
- Vol. 37 (1) , 13-19
An Allergy-Based Approach to Orofacial Granulomatosis: A Narrative Review
The relationship between orofacial granulomatous (OFG) conditions and allergy is evolving. Contact allergies are commonly reported, but the impact of allergy avoidance is unclear, and a current review evaluating this literature has not been performed. We identified 46 studies evaluating the impact of allergen avoidance in OFG (33 case reports, 5 case series, 5 single-arm interventional clinical trials, 1 non-randomized uncontrolled trial, and 2 prospective cohort studies). Patch testing was performed in 158 patients, and the most commonly reported allergens were gold (n = 2), mercury (n = 6), cinnamal/cinnamon (n = 27), sorbic acid (n = 7), grass/silver birch/plant-containing products (n = 22), fragrance (n = 5), nickel (n = 7), and benzoic acid (n = 21). When allergen avoidance was trialed, 123/171 (71%) of patients reported some degree of improvement. A validated scoring/grading system for Granulomatous Cheilitis, Melkerrson-Rosenthal syndrome, and OFG has not been developed, so we were unable to formally assess improvement, instead relying on physician- and patient-reported outcomes in addition to oral disease severity score reporting in several studies. Current literature supports both patch testing and a trial of allergen avoidance/elimination diet to improve OFG in those with a positive result. Few controlled studies have been performed to assess this relationship, and more are needed to evaluate the impact of allergen avoidance. If a patient with difficult-to-treat OFG has a positive patch test and exposure to allergens in their diet, we would recommend a trial of allergen avoidance/elimination diet to facilitate a multimodal approach to improving control of this difficult condition.
- 19 September 2025
- Published by SAGE Publications in Dermatitis®
- Vol. 37 (1) , 13-19
An Allergy-Based Approach to Orofacial Granulomatosis: A Narrative Review
The relationship between orofacial granulomatous (OFG) conditions and allergy is evolving. Contact allergies are commonly reported, but the impact of allergy avoidance is unclear, and a current review evaluating this literature has not been performed. We identified 46 studies evaluating the impact of allergen avoidance in OFG (33 case reports, 5 case series, 5 single-arm interventional clinical trials, 1 non-randomized uncontrolled trial, and 2 prospective cohort studies). Patch testing was performed in 158 patients, and the most commonly reported allergens were gold (n = 2), mercury (n = 6), cinnamal/cinnamon (n = 27), sorbic acid (n = 7), grass/silver birch/plant-containing products (n = 22), fragrance (n = 5), nickel (n = 7), and benzoic acid (n = 21). When allergen avoidance was trialed, 123/171 (71%) of patients reported some degree of improvement. A validated scoring/grading system for Granulomatous Cheilitis, Melkerrson-Rosenthal syndrome, and OFG has not been developed, so we were unable to formally assess improvement, instead relying on physician- and patient-reported outcomes in addition to oral disease severity score reporting in several studies. Current literature supports both patch testing and a trial of allergen avoidance/elimination diet to improve OFG in those with a positive result. Few controlled studies have been performed to assess this relationship, and more are needed to evaluate the impact of allergen avoidance. If a patient with difficult-to-treat OFG has a positive patch test and exposure to allergens in their diet, we would recommend a trial of allergen avoidance/elimination diet to facilitate a multimodal approach to improving control of this difficult condition.
- Open Access
- 1 January 2024
- Published by Taylor & Francis in Clinical, Cosmetic and Investigational Dermatology
- Vol. ume 17, 175-190
Rosacea: Practical Guidance and Challenges for Clinical Management
Rosacea is a common chronic dermatosis. Clinically, rosacea can present with flushing, erythema, papules, pustules, telangiectasias, phymatous changes, pruritus, burning, and stinging. In 2017, the National Rosacea Society Expert Committee recommended a phenotype-based classification for therapy. In this review, we identify monotherapies and multimodal treatment approaches for the clinical management of rosacea including topical, systemic, laser and light, alternative, and combination therapies.
- 1 January 2024
- Published by Taylor & Francis in Clinical, Cosmetic and Investigational Dermatology
- Vol. ume 17, 175-190
Open AccessRosacea: Practical Guidance and Challenges for Clinical Management
Rosacea is a common chronic dermatosis. Clinically, rosacea can present with flushing, erythema, papules, pustules, telangiectasias, phymatous changes, pruritus, burning, and stinging. In 2017, the National Rosacea Society Expert Committee recommended a phenotype-based classification for therapy. In this review, we identify monotherapies and multimodal treatment approaches for the clinical management of rosacea including topical, systemic, laser and light, alternative, and combination therapies.
- Open Access
- 14 March 2023
- Published by Wiley in Clinical Case Reports
- Vol. 11 (3) , e7056
Mycophenolate mofetil–induced hyperlipidemia with cutaneous manifestations
We report a case of a 49 year old woman who developed biopsy‐proven xanthomas on her hands and arms after initiation of Mycophenolate mofetil therapy for systemic lupus erythematosus (SLE) and subsequently went into remission upon cessation of the medication.
- 14 March 2023
- Published by Wiley in Clinical Case Reports
- Vol. 11 (3) , e7056
Open AccessMycophenolate mofetil–induced hyperlipidemia with cutaneous manifestations
We report a case of a 49 year old woman who developed biopsy‐proven xanthomas on her hands and arms after initiation of Mycophenolate mofetil therapy for systemic lupus erythematosus (SLE) and subsequently went into remission upon cessation of the medication.
- Open Access
- 27 January 2023
- Published by Hindawi Limited in Case Reports in Dermatological Medicine
- Vol. 2023, 1-3
Sebaceous Carcinoma of the Penis: A Rare, Dangerous Clinical Entity and the Importance of Immunohistochemistry in Diagnosis
We report a very rare case of pathologically confirmed sebaceous carcinoma of the glans penis with multiple areas of lymphovascular and perineural invasion and multiple lymph node metastases. The importance of immunohistochemical staining in diagnosis is also reviewed.
- 27 January 2023
- Published by Hindawi Limited in Case Reports in Dermatological Medicine
- Vol. 2023, 1-3
Open AccessSebaceous Carcinoma of the Penis: A Rare, Dangerous Clinical Entity and the Importance of Immunohistochemistry in Diagnosis
We report a very rare case of pathologically confirmed sebaceous carcinoma of the glans penis with multiple areas of lymphovascular and perineural invasion and multiple lymph node metastases. The importance of immunohistochemical staining in diagnosis is also reviewed.
- 12 May 2022
- Published by Wiley in International Journal of Dermatology
- Vol. 62 (5) , E278-E279
Reply to: current treatment modalities in granulomatous cheilitis
- 12 May 2022
- Published by Wiley in International Journal of Dermatology
- Vol. 62 (5) , E278-E279
Reply to: current treatment modalities in granulomatous cheilitis
- Open Access
Bullous Pemphigoid and Other Pemphigoid Dermatoses
The pemphigoid family of dermatoses is characterized by autoimmune subepidermal blistering. The classic paradigm for pemphigoid, and the most common member, is bullous pemphigoid. Its variable clinical presentation, with or without frank bullae, is linked by significant pruritus afflicting the elderly. Mucous membrane pemphigoid is an umbrella term for a group of subepidermal blistering dermatoses that favor the mucosal membranes and can scar. Epidermolysis bullosa acquisita is a chronic blistering disorder characterized by skin fragility, sensitivity to trauma, and its treatment-refractory nature. Clinicians that encounter these pemphigoid disorders may benefit from an overview of their clinical presentation, diagnostic work-up, and therapeutic management, with an emphasis on the most frequently encountered pemphigoid disease, bullous pemphigoid.
Open AccessBullous Pemphigoid and Other Pemphigoid Dermatoses
The pemphigoid family of dermatoses is characterized by autoimmune subepidermal blistering. The classic paradigm for pemphigoid, and the most common member, is bullous pemphigoid. Its variable clinical presentation, with or without frank bullae, is linked by significant pruritus afflicting the elderly. Mucous membrane pemphigoid is an umbrella term for a group of subepidermal blistering dermatoses that favor the mucosal membranes and can scar. Epidermolysis bullosa acquisita is a chronic blistering disorder characterized by skin fragility, sensitivity to trauma, and its treatment-refractory nature. Clinicians that encounter these pemphigoid disorders may benefit from an overview of their clinical presentation, diagnostic work-up, and therapeutic management, with an emphasis on the most frequently encountered pemphigoid disease, bullous pemphigoid.
- 1 October 2021
- Published by Wiley in British Journal of Dermatology
- Vol. 185 (4) , 868-869
Response to 'A call to standardize the BCC: SCC ratio'
Jiyad et al. highlighted the importance of standardizing the calculation for the ratio of basal cell carcinoma (BCC) to squamous cell carcinoma (SCC) by accounting for tumor‐based incidence, age, sex, and latitude of residence [1]. Through uniform calculation, ratios can be compared across populations and over time to monitor trends and identify risk factors [1].
- 1 October 2021
- Published by Wiley in British Journal of Dermatology
- Vol. 185 (4) , 868-869
Response to 'A call to standardize the BCC: SCC ratio'
Jiyad et al. highlighted the importance of standardizing the calculation for the ratio of basal cell carcinoma (BCC) to squamous cell carcinoma (SCC) by accounting for tumor‐based incidence, age, sex, and latitude of residence [1]. Through uniform calculation, ratios can be compared across populations and over time to monitor trends and identify risk factors [1].
- 2 September 2021
- Published by Wiley in International Journal of Dermatology
- Vol. 61 (11) , E421
Reply: “IFN‐α and TNF‐α serum levels and their association with disease severity in Egyptian children and adults with alopecia areata”
- 2 September 2021
- Published by Wiley in International Journal of Dermatology
- Vol. 61 (11) , E421
Reply: “IFN‐α and TNF‐α serum levels and their association with disease severity in Egyptian children and adults with alopecia areata”
- 9 August 2021
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 35 (12) , E930-E931
Reply to: low response of granulomatous cheilitis to currently established treatments
- 9 August 2021
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 35 (12) , E930-E931
Reply to: low response of granulomatous cheilitis to currently established treatments